| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |